Advertisement
Document › Details
Gilde Healthcare Partners. (9/2/24). "Press Release: Gilde Healthcare Appoints Jan Willem Bakker as Head of Investor Relations". Utrecht.
Gilde Healthcare, the transatlantic specialist investment firm, is pleased to announce the addition of Jan Willem Bakker to its team as Partner & Head of Investor Relations.
Jan Willem will focus on Gilde Healthcare’s investor relations activities and contribute to the firm’s capital raising, marketing and communications efforts. With over 20 years of experience in client facing roles in financial services he brings vast experience to benefit existing and new LPs of the Gilde Healthcare platform. “We are pleased to welcome Jan Willem to our Investor Relations and Fundraising team,” said Pieter van der Meer, Managing Partner of Gilde Healthcare. “His extensive track record with institutional investors both as an LP and GP, strong industry relationships, and entrepreneurial mindset will help in strengthening our fundraising strategy and investor relationships. He will be instrumental in the foreseen expansion of our fund platform with impactful private equity strategies.”
Prior to joining Gilde Healthcare, Jan Willem was a partner at Prime Ventures having previously held senior roles at Arcano Partners and Adveq Management AG (now Schroders Capital), during his time at Adveq Jan Willem was a board member of the Dutch Private Equity association (NVP). He began his career in financial services at Kas Bank N.V. “I am very happy to join Gilde Healthcare’s ambitious team and contribute to building out its impactful platform. I look forward to collaborating with existing and prospective investors, investment and finance teams on delivering innovative and successful investment solutions to benefit a range of stakeholders.” said Jan Willem.
About Gilde Healthcare
Gilde Healthcare is a transatlantic specialist investment firm managing over €2.6 billion across two fund strategies: Venture&Growth and Private Equity. The Venture&Growth fund of Gilde Healthcare invests in fast growing companies active in digital health, medtech and therapeutics, based in Europe and North America. The Private Equity fund of Gilde Healthcare participates in profitable lower mid-market healthcare companies based in North-Western Europe. For more information, visit the company’s website at www.gildehealthcare.com.
Record changed: 2024-09-12 |
Advertisement
More documents for Gilde Investment (Group)
- [1] Karius, Inc.. (5/2/24). "Press Release: Karius Raises $100M Co-Led by Khosla Ventures, 5AM Ventures and Gilde Healthcare". Redwood City, CA....
- [2] Gilde Healthcare Partners. (11/15/23). "Press Release: Gilde Healthcare Closes New Venture&Growth Fund at €740 Million Hard Cap". Utrecht....
- [3] Gilde Healthcare Partners. (6/9/23). "Press Release: Gilde Healthcare Strengthens Investor Relations and Fundraising Team with Besmire Ahmati". Utrecht....
- [4] Gilde Healthcare Partners. (6/5/23). "Press Release: Gilde Healthcare Strengthens US Venture&Growth Team with Rich Wilmot as Partner". Garching....
- [5] Gilde Healthcare Partners. (4/19/23). "Press Release: Gilde Healthcare Raises €600 Million to Invest in Healthcare innovation". Utrecht....
- [6] Gilde Healthcare Partners. (8/29/22). "Press Release: Gilde Healthcare Acquires Sanquin Reagents". Utrecht....
- [7] Gilde Healthcare Partners. (7/12/22). "Press Release: Gilde Healthcare Bolsters Its Private Equity Team in Frankfurt Office". Utrecht & Frankfurt a. M.....
- [8] Synexa Life Sciences B.V.. (5/18/22). "Press Release: Synexa Life Sciences Announces Strategic Growth Plans and Strengthening of Its Executive Team". Leiden....
- [9] Gilde Healthcare Partners. (3/16/22). "Press Release: Gilde Healthcare Raises more than €500 Million for Private Equity Investments in European Healthcare Companies". Utrecht....
- [10] Gilde Healthcare Partners. (12/14/21). "Press Release: Philips Acquires Gilde Portfolio Company Vesper Medical to Further Expand Its Image-guided Therapy Devices Portfolio". Amsterdam & Utrecht....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top